⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9261833 | 0.92 | EP300 (0.50) | — | |
| SCHEMBL1655438 | 0.92 | EP300 (0.50) | — | |
| SCHEMBL1653060 | 0.90 | EP300 (0.54) | — | |
| SCHEMBL159932 | 0.83 | — | — | |
| SCHEMBL6034303 | 0.81 | — | — | |
| SCHEMBL21002254 | 0.81 | — | — | |
| SCHEMBL6034301 | 0.81 | — | — | |
| SCHEMBL9013163 | 0.79 | EP300 (0.41) | — | |
| Methacrylic Acid SCHEMBL27516627 | 0.78 | EP300 (0.52) | — | |
| SCHEMBL27966789 | 0.77 | EP300 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4362916-A1 | AQUEOUS GEL COMPOSITION | Acousia Therapeutics GmbH (DE) | 2024-05-08 | — | — | EP | claimed |
| WO-2023222795-A1 | AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2023-11-23 | — | — | WO | claimed |
| EP-3419588-A1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | Outplay Inc. (CA) | 2019-01-02 | — | — | EP | claimed |
| WO-2017145030-A1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | OUTPLAY INC. (CA) | 2017-08-31 | — | — | WO | claimed |
| WO-2017144937-A1 | COMPOSITIONS FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | OUTPLAY INC. (CA) | 2017-08-31 | — | — | WO | claimed |
| WO-2011047422-A1 | ANTI-ACNE COMPOSITION AND USE THEREOF | CHEMEQ LTD (AU) | 2011-04-28 | — | — | WO | claimed |
| WO-2011034569-A1 | NOVEL MODIFIED FATTY ACID ESTERS AND METHOD OF PREPARATION THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2011-03-24 | — | — | WO | claimed |
| WO-2008012733-A2 | METHOD AND COMPOSITION FOR PERMANENTLY SHAPING HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-31 | — | — | WO | claimed |
| WO-2024115212-A1 | WAX ESTERS | EVONIK OPERATIONS GMBH (DE) | 2024-06-06 | — | — | WO | disclosed |
| EP-4362916-A1 | AQUEOUS GEL COMPOSITION | Acousia Therapeutics GmbH (DE) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024042191-A1 | ORAL CARE COMPOSITIONS | BLISSANDMORE GMBH (DE) | 2024-02-29 | — | — | WO | disclosed |
| EP-4294785-A1 | AQUEOUS COMPOSITIONS COMPRISING 6-UNDECANOL-ESTERS | Evonik Operations GmbH (DE) | 2023-12-27 | — | — | EP | disclosed |
| WO-2023222795-A1 | AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2023-11-23 | — | — | WO | disclosed |
| EP-4025571-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2022-07-13 | — | — | EP | disclosed |
| WO-2005007766-A1 | ADHESIVE EPOXY COMPOSITION AND PROCESS FOR APPLYING IT | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-01-27 | — | — | WO | disclosed |
| EP-1080126-A1 | METHOD OF BONDING A WINDOW TO A SUBSTRATE USING A SILANE FUNCTIONAL ADHESIVE COMPOSITION | ESSEX SPECIALTY PRODUCTS, INC. (US) | 2001-03-07 | — | — | EP | disclosed |
| EP-1076679-A1 | CURE ON DEMAND ADHESIVES AND WINDOW MODULE WITH CURE ON DEMAND ADHESIVE THEREON | THE DOW CHEMICAL COMPANY (US) | 2001-02-21 | — | — | EP | disclosed |
| WO-1999055755-A1 | METHOD OF BONDING A WINDOW TO A SUBSTRATE USING A SILANE FUNCTIONAL ADHESIVE COMPOSITION | ESSEX SPECIALTY PRODUCTS, INC. (US) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999055753-A1 | CURE ON DEMAND ADHESIVES FOR ASSEMBLING SHOE SOLES | THE DOW CHEMICAL COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999055794-A1 | CURE ON DEMAND ADHESIVES AND WINDOW MODULE WITH CURE ON DEMAND ADHESIVE THEREON | THE DOW CHEMICAL COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |